english.prescrire.org > Spotlight > Archives : 2019 > Gliptins: joint pain and exposure to NSAIDs

Spotlight: Archives

Every month, the subjects in Prescrire’s Spotlight.

2019 : 1 | 30 | 60

In the November issue of Prescrire International - Gliptins: joint pain and exposure to NSAIDs

FREE DOWNLOAD In the Adverse Effects section of the November issue, the results of a study by the independent French medical journal Prescrire, based on data from France's national health insurance system.
Full text available for free download.

Summary

  • Joint and muscle pain are part of the adverse effect profile of gliptins.
     
  • In France, Prescrire carried out a study, using data from the mandatory national health insurance system, showing that patients taking gliptins are more frequently exposed to nonsteroidal anti-inflammatory drugs (NSAIDs) than patients taking other hypoglycaemic drugs for type 2 diabetes.
     
  • These patients are therefore more often exposed to the adverse effects of NSAIDs, without any demonstrated advantage with respect to their diabetes.

Full text available for free download.

 ©Prescrire 1 November 2019

"Gliptins: joint pain and exposure to NSAIDs" Prescrire Int 2019; 28 (209): 268. (Pdf, free).

Share Share on Facebook Share on Twitter
Share
Partager sur Facebook Partager sur Twitter

 
Download the full review
Pdf, free